main
function
memori
cell
provid
protect
upon
reexposur
pathogen
prevent
reemerg
lowgrad
persist
pathogen
memori
cell
achiev
function
high
frequenc
elev
activ
state
lead
rapid
respons
upon
antigen
challeng
signific
characterist
memori
cell
viral
infect
studi
extens
mani
studi
tcell
memori
experiment
viral
immunologist
go
great
length
assur
anim
coloni
free
endogen
pathogen
order
design
reproduc
experi
experiment
result
thought
provid
basi
understand
human
immun
respons
virus
although
find
enlighten
human
immunolog
often
memori
tcell
popul
crossreact
respond
new
infecti
agent
crossreact
alloantigen
influenc
success
tissu
transplant
crossreact
cell
becom
activ
modul
immun
respons
outcom
subsequ
heterolog
infect
phenomenon
term
heterolog
immun
larg
memori
popul
also
accommod
finit
immun
system
requir
host
make
room
new
popul
memori
cell
appear
memori
cell
part
continu
evolv
interact
network
new
infect
alter
frequenc
distribut
activ
memori
cell
gener
respons
previou
infect
alloantigen
antigenspecif
memori
tcell
popul
import
protect
subsequ
infect
divers
tcell
receptor
tcr
repertoir
also
intrins
crossreact
tcr
cell
discrimin
peptid
usual
eight
amino
acid
embed
major
histocompat
complex
class
mhci
molecul
crystal
structur
studi
reveal
tcr
contact
residu
peptid
present
mhc
molecul
requir
activ
although
tcr
toler
certain
amino
acid
substitut
peptid
sequenc
still
becom
activ
exampl
amino
acid
substitut
human
leukocyt
antigen
hla
epstein
barr
viru
ebv
peptid
posit
toler
substitut
posit
crucial
cytotox
tlymphocyt
recognit
thu
molecular
mimicri
wherebi
peptid
ligand
differ
origin
ligand
retain
site
necessari
interact
tcr
one
sever
path
crossreact
tcell
respons
howev
altern
explan
flexibl
tcr
bind
may
explain
thermodynam
studi
tcr
peptid
mhc
interact
tcr
undergo
conform
chang
tcr
complementar
determin
region
proper
accommod
cognat
antigen
seen
human
cell
bind
epitop
mous
cell
bind
cytochrom
c
epitop
mcc
k
wu
et
al
suggest
induc
fit
model
abtcr
low
conform
complementar
peptidemhc
first
contact
mhc
molecul
via
loop
follow
readjust
flexibl
loop
peptid
mhc
complex
flexibl
molecul
lead
enhanc
abil
singl
tcr
accommod
structur
divers
peptid
possibl
kinet
flexibl
tcr
may
also
lead
differ
region
tcr
interact
differ
site
two
separ
ligand
term
altern
recognit
anoth
mechan
tcell
crossreact
abil
cell
express
two
differ
tcr
due
incomplet
allel
exclus
tcra
chain
mathemat
calcul
suggest
singl
tcr
abl
react
differ
nonam
peptid
taken
togeth
mechan
make
crossreact
difficult
predict
fairli
common
event
crossreact
may
valuabl
host
consid
larg
number
potenti
pathogen
antigen
one
expos
lifetim
crossreact
could
compens
situat
limit
tcr
repertoir
still
allow
normal
immun
respons
instanc
mice
defici
enzym
termin
deoxynucleotidyl
transferas
tdt
impair
diversif
tcr
repertoir
calcul
wildtyp
mice
upon
lymphocyt
choriomening
viru
lcmv
sendai
viru
infect
mice
rel
normal
immun
respons
recov
infect
tdtdefici
mice
report
cell
highli
crossreact
profil
compar
wildtyp
mice
thu
may
compens
less
divers
tcr
repertoir
addit
mani
tcr
transgen
mice
limit
tcr
divers
capabl
respond
mani
antigen
resist
viral
infect
report
pathogenspecif
memori
cell
recogn
crossreact
epitop
differ
protein
pathogen
protein
close
relat
total
unrel
pathogen
increas
review
perhap
surpris
crossreact
tcell
respons
seen
direct
evolutionarili
conserv
site
within
viru
group
differ
strain
influenza
viru
dengu
viru
conserv
site
differ
member
viru
group
hantavirus
arenavirus
flavivirus
howev
exampl
crossreact
tcell
respons
involv
complet
unrel
virus
lcmv
vaccinia
viru
vv
influenza
viru
hepat
c
viru
hcv
influenza
viru
ebv
influenza
viru
human
immunodefici
viru
hiv
human
papillomaviru
coronaviru
shown
crossreact
tcell
respons
frequent
observ
memori
tcell
popul
gener
due
increas
frequenc
higher
activ
state
memori
cell
crossreact
immun
respons
present
alter
tcell
dynam
consider
consequ
pathogenesi
infect
either
inhibit
enhanc
replic
newli
encount
heterolog
viru
also
signific
impact
allospecif
tcell
activ
prior
follow
transplant
addit
autoimmun
associ
viral
infect
like
individu
histori
viru
infect
uniqu
composit
crossreact
memori
tcell
pool
may
either
initi
reactiv
cell
autoimmun
potenti
crossreact
immunodomin
tcr
divers
although
hundr
peptid
viral
infect
appropri
sequenc
bind
mhci
usual
small
number
epitop
stimul
immunogen
respons
tcell
memori
pool
creat
viru
infect
distinct
hierarchi
epitopespecif
respons
host
viral
epitop
domin
stimul
high
frequenc
tcell
respons
other
subdomin
stimul
weaker
bare
detect
tcell
respons
immunodomin
hierarchi
regul
variou
paramet
includ
effici
process
present
peptid
affin
peptid
mhci
avail
cell
tcr
recogn
peptidemhc
complex
competit
cell
domain
antigenpres
cell
apc
mani
epitopespecif
respons
distinct
tcr
amino
acid
motif
maintain
clonotyp
differ
individu
exampl
human
influenza
respons
amino
acid
motif
irss
common
drestrict
respons
mice
sxg
first
three
posit
region
common
motif
bind
motif
identifi
includ
murin
b
restrict
nucleoprotein
np
respons
gxxn
lcmv
infect
hiv
env
respons
gqg
conserv
amino
acid
motif
suggest
site
requir
tcr
bind
mhc
ligand
structur
similar
vb
usag
amino
acid
motif
well
conserv
immunodomin
hierarchi
thought
public
specif
epitopespecif
tcell
respons
similar
individu
despit
public
specif
tcell
respons
tremend
divers
tcr
repertoir
individu
tcr
usag
per
epitop
differ
individu
host
even
though
might
gener
similar
prefer
tcr
vb
usag
specif
amino
acid
motif
thu
tcr
antigenspecif
tcell
clone
uniqu
individu
uniqu
region
refer
privat
specif
epitopespecif
respons
variat
probabl
consequ
random
stochast
process
tcr
rearrang
thymu
result
variat
peripher
tcr
repertoir
random
stochast
process
wherebi
tcell
encount
apc
present
cognat
ligand
tcell
clone
stimul
earli
may
domin
respons
interf
stimul
cell
privat
specif
crossreact
memori
alter
subsequ
immun
repertoir
memori
tcell
specif
epitop
unrel
pathogen
high
frequenc
activ
state
memori
cell
give
advantag
cell
lead
preferenti
expans
crossreact
tcell
popul
crossreact
expans
alter
hierarchi
tcell
respons
saw
sequenti
heterolog
viru
infect
mice
two
distantli
relat
arenavirus
lcmv
pichind
viru
pv
virus
encod
epitop
np
six
eight
amino
acid
common
epitop
normal
subdomin
either
viru
host
howev
due
select
expans
np
specif
crossreact
memori
cell
np
specif
tcell
respons
becam
domin
lcmvimmun
mice
infect
pv
pvimmun
mice
infect
lcmv
data
support
concept
expans
crossreact
tcell
popul
substanti
contribut
immun
hierarchi
tcell
respons
studi
may
explain
variabl
immunodomin
hierarchi
observ
human
viral
infect
host
expos
numer
infect
throughout
life
instanc
patient
ident
haplotyp
infect
hiv
hcv
show
high
variabl
tcell
immun
hierarchi
interestingli
crossreact
tcell
respons
pathogen
document
virus
studi
vv
infect
lcmvimmun
mice
show
vv
sometim
elicit
expans
cell
one
lcmv
epitop
specif
time
elicit
expans
cell
differ
specif
outcom
could
explain
stochast
natur
clonal
domin
privat
specif
antigenspecif
tcr
repertoir
immun
host
thu
proport
epitopespecif
memori
cell
crossreact
anoth
antigen
would
differ
host
host
variat
inde
observ
lcmvimmun
host
challeng
vv
studi
predict
lcmvencod
epitop
might
drive
crossreact
respons
vv
substanti
variabl
note
individu
mice
test
mice
vv
infect
stimul
strong
expans
cell
specif
lcmv
np
epitop
mice
specif
either
glycoprotein
gp
gp
overlap
epitop
mice
specif
gp
epitop
fig
often
expans
cell
specif
one
lcmv
epitop
sometim
cell
specif
one
epitop
expand
question
whether
variat
expans
repres
random
stochast
event
lcmvimmun
mous
challeng
vv
limit
number
crossreact
cell
actual
engag
antigen
whether
mous
uniqu
tcell
repertoir
regard
potenti
crossreact
vv
address
point
carboxyfluorescein
succinimidyl
ester
csfe
label
splenocyt
differ
donor
lcmvimmun
mice
adopt
transfer
three
recipi
challeng
vv
pattern
epitopespecif
tcell
expans
virtual
ident
among
recipi
singl
donor
differ
recipi
differ
donor
result
show
variat
tcell
respons
reflect
privat
specif
individu
immun
host
although
high
level
tcell
crossreact
involv
two
lcmv
pv
np
epitop
regard
peptideinduc
interferong
ifng
product
heterolog
viru
challeng
select
small
subset
crossreact
cell
lead
substanti
narrow
tcr
repertoir
narrow
repertoir
differ
pattern
individu
adopt
transfer
studi
indic
variat
reflect
privat
specif
immun
system
develop
primari
infect
studi
except
link
narrow
tcr
repertoir
poor
viral
clearanc
enhanc
probabl
select
epitop
escap
variant
thu
privat
specif
memori
tcr
repertoir
add
anoth
level
complex
understand
crossreact
tcell
respons
explain
variabl
diseas
outcom
upon
infect
pathogen
crossreact
protect
immun
memori
cell
crossreact
heterolog
viru
provid
partial
protect
immun
experiment
model
provid
differ
life
death
infect
host
tabl
exampl
lcmvimmun
mice
control
pv
infect
presum
due
crossreact
cell
specif
subdomin
np
epitop
lcmvimmun
mice
also
manifest
strong
protect
immun
infect
larg
dna
poxviru
vv
compar
mice
respiratori
model
infect
heterolog
immun
prevent
mortal
otherwis
lethal
dose
vv
adopt
transfer
studi
demonstr
cell
lcmvimmun
mice
requir
transfer
protect
immun
mice
challeng
pv
vv
tenuou
balanc
tcell
immunodomin
protect
immun
immunopatholog
heterolog
immun
alway
benefici
although
immun
lcmv
protect
respiratori
vv
infect
inhibit
clearanc
respiratori
syncyti
viru
rsv
similarli
work
demonstr
histori
influenza
infect
protect
vv
inhibit
clearanc
murin
cytomegaloviru
mcmv
lcmv
tabl
lack
reciproc
although
lcmv
immun
protect
vv
immun
vv
protect
lcmv
correspondingli
although
vv
elicit
prolifer
subset
csfelabel
adopt
transfer
lcmv
memori
cell
lcmv
stimul
littl
prolifer
vvimmun
popul
sinc
vv
encod
protein
perhap
thousand
potenti
epitop
probabl
much
like
encod
epitop
would
activ
cell
lcmvimmun
tcell
popul
wherea
lcmv
encod
four
protein
far
limit
number
epitop
may
less
like
encount
vvimmun
tcell
stimul
find
could
explain
mani
larg
dna
virus
evolv
encod
gene
product
interfer
mhci
antigen
present
factor
may
also
involv
instanc
vv
might
better
induc
lcmv
could
lead
enhanc
ifng
product
crossreact
cell
select
expans
lcmvspecif
memori
cell
upon
vv
infect
suggest
possibl
crossreact
tcell
respons
two
virus
base
concept
molecular
mimicri
identifi
crossreact
epitop
search
vv
sequenc
homolog
lcmv
np
epitop
fig
epitop
gener
tcell
respons
highli
crossreact
three
lcmvspecif
memori
tcell
respons
np
gp
gp
incident
show
crossreact
one
pvspecif
respons
np
anoth
vv
epitopespecif
respons
unpublish
data
henc
whole
matrix
crossreact
reveal
one
vv
epitop
could
activ
five
differ
memori
popul
impact
heterolog
immun
signific
howev
stimul
cell
line
deriv
individu
lcmvimmun
donor
line
differ
pattern
crossreact
high
one
epitop
other
high
differ
epitop
reflect
privat
specif
crossreact
unpublish
data
crossreact
alter
patholog
cell
mediat
protect
immun
also
substanti
immunopatholog
lcmv
infect
cell
clear
viru
also
mediat
sever
leptomening
tcellmedi
patholog
acut
infect
like
result
inflammatori
condit
induc
presenc
high
number
cell
lyse
infect
tissu
produc
proinflammatori
cytokin
chemokin
recruit
cell
diseas
outcom
ultim
base
fine
balanc
number
memori
cell
recruit
site
viral
replic
effici
length
time
cell
present
amplifi
proinflammatori
respons
viru
clear
effici
activ
cell
viral
clearanc
least
partial
depend
avid
tcr
interact
ligand
studi
alter
peptid
ligand
apl
repres
vitro
model
crossreact
respons
show
highand
lowpot
ligand
differ
length
time
tcr
interact
mhcligand
ie
tcr
avid
modifi
function
potenti
individu
clone
studi
help
explain
lower
avid
crossreact
respons
may
protect
well
heterolog
viru
heterolog
immun
may
effect
mediat
protect
immun
homolog
immun
easi
imagin
enhanc
earli
activ
lower
avid
crossreact
clone
might
ineffici
protect
could
lead
differ
type
immunopatholog
heterolog
immun
alter
patholog
mice
exampl
balanc
tcell
immun
patholog
seen
vv
infect
lcmvimmun
mice
lcmvimmun
mice
challeng
vv
develop
pannicul
present
necrosi
viscer
fat
analog
human
erythema
nodosum
respiratori
infect
model
reduc
mortal
lcmvimmun
mice
infect
vv
accompani
alter
lung
patholog
lung
infiltr
lcmvspecif
cell
contribut
obstruct
bronchiol
fibrin
inflammatori
cell
bronchiol
obliteran
human
erythema
nodosum
bronchiol
obliteran
unknown
etiolog
seen
viral
bacteri
infect
also
associ
autoimmun
diseas
erythema
nodosum
observ
vaccin
smallpox
hepat
b
develop
bronchiol
obliteran
lung
allograft
associ
transplant
reject
alter
patholog
also
occur
influenzaimmun
mice
augment
viral
replic
upon
lcmv
mcmv
infect
instead
usual
mild
mononuclear
infiltr
observ
acut
mcmv
infect
mice
influenzaimmun
mice
infect
mcmv
develop
sever
consolid
mononuclear
pneumonia
evid
bronchiol
bronchiol
alveolar
epithelium
replac
bronchiolarlik
cell
indic
lung
repair
heterolog
immun
alter
patholog
human
manifest
heterolog
immun
may
therefor
explain
variat
human
diseas
pathogenesi
thought
previous
affect
genet
differ
physiolog
condit
patient
inocul
rout
dose
individu
histori
infect
may
shape
tcell
memori
pool
way
contribut
variabl
heterolog
immun
crossreact
tcell
respons
reminisc
phenomenon
origin
antigen
sin
first
describ
bcell
respons
influenza
viru
subtyp
differ
strain
variant
influenza
viru
commonli
crossreact
tcell
level
mice
human
lead
specul
crossreact
cell
may
involv
pathogenesi
influenza
viru
infect
perhap
recogn
human
exampl
heterolog
immun
come
dengu
viru
infect
infect
dengu
viru
serotyp
gener
cell
higher
avid
second
presum
previous
encount
dengu
viru
serotyp
suggest
crossreact
memori
cell
preferenti
expand
cell
greater
avid
serotyp
caus
infect
lower
avid
crossreact
cell
may
mediat
sever
diseas
outcom
includ
hemorrhag
fever
observ
subsequ
infect
differ
dengu
viru
serotyp
differ
clinic
asymptomat
acut
ebv
infect
magnitud
tcell
respons
viral
load
symptomat
diseas
form
acut
infecti
mononucleosi
syndrom
less
like
young
children
teenag
young
adult
longer
histori
infect
presum
complex
pool
memori
cell
young
children
infect
follow
similar
pattern
includ
mump
chicken
pox
polio
measl
subset
cell
direct
major
immunodomin
ebv
epitop
bmlfinfluenza
viru
epitop
analog
vvlcmv
matrix
center
ebv
epitop
unpublish
data
fig
analys
tcr
repertoir
two
individu
experienc
ebvassoci
acut
infecti
mononucleosi
howev
reveal
substanti
differ
hierarchi
jb
usag
healthi
influenza
immun
donor
suggest
skew
subset
specif
tcr
repertoir
probabl
crossreact
ebv
stimul
prolifer
interestingli
crossreact
cell
apl
studi
behav
differ
function
respons
ligand
crossreact
cell
bound
tetram
produc
tumor
necrosi
factor
tnfa
ifng
macrophag
inflammatori
protein
ligand
bound
one
tetram
produc
tnfa
ifng
altern
ligand
bound
one
tetram
abl
produc
altern
ligand
would
appear
crossreact
tcell
interact
altern
ligand
highli
variabl
function
pattern
tcell
crossreact
inde
heterogen
henc
multipl
techniqu
requir
detect
tcell
crossreact
includ
tetram
stain
differ
function
assay
potenti
import
factor
tcr
interact
ligand
tcr
avid
interact
crossreact
tcell
altern
ligand
could
weak
stabli
bind
tetram
could
suffici
induc
distinct
hierarchi
cytokin
product
analog
observ
influenza
clone
unabl
bind
tetram
produc
ifng
follow
peptid
stimul
extrem
variabl
pathogenesi
hcv
human
rang
asymptomat
fulmin
steril
persist
infect
heterolog
immun
may
play
role
variabl
hcv
encod
epitop
share
six
eight
amino
acid
influenza
epitop
na
cell
influenzaimmun
individu
evid
past
hcv
infect
often
respond
hcv
epitop
vitro
henc
human
popul
may
partial
immun
hcv
consequ
crossreact
pronounc
crossreact
tcell
respons
influenza
hcv
note
patient
hcv
infect
result
narrow
repertoir
singl
epitop
patient
experienc
fulmin
necrot
hepat
far
sever
patient
mount
divers
tcell
respons
patient
would
like
immun
ubiquit
influenza
viru
suggest
privat
specif
may
dictat
alter
immun
respons
heterolog
immun
immun
deviat
immun
previous
encount
virus
alter
cytokin
respons
subsequ
viru
encount
prior
immun
lcmv
induc
much
higher
level
ifng
lower
level
upon
vv
infect
much
enhanc
ifng
product
come
directli
lcmv
epitopespecif
cell
activ
vv
infect
immun
influenza
protect
mice
sever
diseas
caus
infect
rsv
rsv
gprotein
vaccin
shift
usual
thelper
respons
respons
prevent
sever
eosinophil
infiltr
lung
chang
respons
due
infect
vaccin
earli
childhood
might
explain
children
like
develop
allergi
other
sever
studi
report
benefici
effect
earli
infect
childhood
develop
asthma
may
consequ
earli
skew
memori
pool
toward
phenotyp
would
inhibit
allerg
respons
impact
heterolog
immun
extend
field
transplant
viral
infect
influenc
gener
cellular
immun
respons
alloantigen
associ
reject
foreign
tissu
transplant
contribut
heterolog
immun
induct
allospecif
immun
respons
support
evid
virusspecif
cell
crossreact
alloantigen
crossreact
provid
mechan
observ
activ
allospecif
cell
follow
infect
detect
memori
allospecif
cell
within
individu
previous
expos
alloantigen
activ
allospecif
cell
viral
infect
present
uniqu
obstacl
transplant
foreign
tissu
induct
transplant
toler
detect
allospecif
cell
tcell
repertoir
contain
larg
number
allospecif
cell
may
recruit
virusspecif
tcell
respons
frequenc
allospecif
cell
estim
rang
total
cell
use
limit
dilut
cell
outgrowth
techniqu
howev
protocol
optim
quantif
directli
ex
vivo
requir
lengthi
period
vitro
cultur
may
accur
reflect
frequenc
allospecif
cell
vivo
recent
intracellular
cytokin
assay
util
detect
allospecif
cell
effici
directli
ex
vivo
adopt
cytokin
assay
specif
identifi
cell
cell
previous
thought
acquir
cytokineproduc
effector
function
undergo
differenti
process
demonstr
cell
rapidli
produc
tnfa
ifng
follow
tcr
engag
vitro
use
tnfa
product
marker
allospecif
cell
readili
detect
directli
ex
vivo
frequenc
rang
total
cell
allospecif
cell
distinguish
effectormemori
allospecif
cell
differenti
product
tnfa
ifng
effector
memori
cell
produc
cytokin
unpublish
data
crossreact
natur
antigen
recognit
cell
suggest
allospecif
cell
may
activ
viral
infect
initi
result
laboratori
demonstr
acut
infect
mice
lcmv
stimul
allospecif
cytotox
broad
rang
foreign
haplotyp
vitro
kill
allogen
target
cell
detect
seven
day
infect
primarili
mediat
cell
allospecif
cell
activ
infect
lcmv
also
detect
product
ifng
respons
allogen
target
infect
mice
virus
includ
pv
vv
mcmv
also
stimul
allospecif
tcell
cytotox
suggest
gener
phenomenon
follow
infect
cytotox
allospecif
cell
also
found
human
infect
ebv
acut
infecti
mononucleosi
heterolog
immun
import
mechan
activ
allospecif
cell
follow
infect
tcell
crossreact
virus
alloantigen
demonstr
numer
infect
model
tcell
clone
deriv
mice
infect
lcmv
influenza
viru
vsv
human
infect
ebv
herp
simplex
viru
studi
examin
crossreact
lcmvspecif
cell
alloantigen
show
crossreact
broadbas
portion
cell
specif
four
lcmv
epitop
examin
gp
np
gp
np
crossreact
antigen
determin
product
ifng
howev
crossreact
antigen
broad
also
distinct
differ
proport
epitopespecif
popul
recogn
allogen
target
distinct
natur
crossreact
clearli
evid
lcmvspecif
cell
k
antigen
still
broadbas
also
select
two
four
lcmvepitop
examin
gp
np
crossreact
result
suggest
viral
infect
dramat
alter
tcell
repertoir
unexpect
manner
activ
allospecif
cell
infect
may
account
presenc
allospecif
cell
memori
phenotyp
individu
previous
expos
alloantigen
inde
acut
lcmv
infect
resolv
memori
phenotyp
allospecif
cell
remain
present
rest
immun
state
activ
allospecif
cell
viral
infect
may
import
consequ
transplant
foreign
tissu
mainten
graft
function
viral
infect
demonstr
rapidli
induc
tcellmedi
reject
allogen
splenocyt
implant
mice
studi
fate
allogen
cell
implant
virusinfect
mice
monitor
use
vivo
cytotox
assay
assay
allow
tcellmedi
reject
cfselabel
allogen
splenocyt
examin
vivo
within
h
transfer
vivo
cytotox
assay
also
detect
natur
killer
nk
cellmedi
reject
allogen
splenocyt
specif
examin
tcelldepend
mechan
nk
cell
need
deplet
transfer
target
splenocyt
infect
mice
either
lcmv
pv
induc
tcelldepend
mechan
reject
implant
allogen
splenocyt
first
detect
one
day
infect
reach
peak
level
day
three
postinfect
virusinduc
tcelldepend
reject
surpris
occur
earli
time
point
infect
nk
cell
function
peak
outcom
could
either
due
allospecif
cell
crossreact
viral
antigen
due
vigor
primari
tcell
respons
implant
allogen
cell
wake
rich
cytokin
environ
creat
acut
infect
tradit
method
prolong
surviv
allogen
tissu
graft
involv
use
chronic
immunosuppress
prevent
gener
donorspecif
immun
respons
use
costimul
blockad
toler
cell
specif
donor
tissu
proven
promis
altern
approach
achiev
longterm
surviv
transplant
tissu
without
need
gener
immunosuppress
howev
recent
studi
demonstr
acut
viral
infect
serious
diminish
efficaci
toleranceinduc
protocol
acut
infect
mice
virus
lcmv
pv
within
day
posttranspl
persist
infect
lcmv
interf
induct
toler
alloantigen
result
rapid
reject
allogen
skin
graft
deplet
cell
lcmvinfect
recipi
mice
significantli
delay
reject
skin
allograft
support
role
cell
mediat
reject
inabl
poli
c
vv
mcmv
abrog
toler
condit
suggest
product
cytokin
alon
suffici
induc
reject
mechan
mediat
virusinduc
abrog
transplant
toler
still
remain
clarifi
though
could
involv
crossreact
although
cytokinemedi
disrupt
toler
evid
time
point
transplant
mice
treat
tolllik
receptor
tlr
agonist
poli
c
lipopolysaccharid
prior
transplant
allogen
tissu
effect
toler
suggest
earli
stage
toler
induct
sensit
cytokinedepend
mechan
find
suggest
ongo
viral
infect
impedi
use
costimul
blockad
induct
toler
human
presenc
memori
allospecif
cell
associ
acceler
reject
allogen
tissu
transplant
recipi
memori
allospecif
cell
gener
exposur
alloantigen
also
refractori
effect
costimul
blockad
memori
cell
less
reliant
costimulatori
signal
activ
memori
allospecif
cell
gener
infect
also
refractori
costimul
blockad
mice
previous
infect
lcmv
possess
memori
phenotyp
allospecif
cell
suffici
toler
costimul
blockad
accept
allogen
skin
graft
moreov
sequenti
infect
mice
heterolog
virus
gener
higher
frequenc
allospecif
memori
cell
increas
resist
costimul
blockad
result
suggest
individu
histori
infect
influenc
respons
alloantigen
histori
import
factor
design
novel
methodolog
achiev
optim
graft
surviv
human
due
larg
complex
memori
popul
heterolog
immun
unrel
pathogen
great
impact
stabil
memori
tcell
pool
homeostasi
cell
tightli
regul
phenomenon
rest
state
rel
fix
proport
cell
somewhat
fix
proport
memori
cell
individu
age
thymu
sourc
cell
involut
proport
increas
memori
phenotyp
phenotyp
cell
distinct
bona
fide
memori
cell
cell
possess
memorylik
antigen
phenotyp
import
one
mous
memori
marker
express
cell
receiv
foreign
antigen
signal
go
program
prolifer
contract
becom
bona
fide
memori
cell
express
cell
introduc
lymphopen
environ
environ
stimul
cell
respond
selfantigen
perhap
microbi
flora
acquir
memori
phenotyp
fill
avail
space
go
differenti
scheme
bona
fide
memori
cell
cell
thu
product
homeostat
prolifer
refer
hp
cell
type
memori
phenotyp
cell
bona
fide
memori
cell
includ
classic
nkt
cell
bear
invari
tcra
chain
nkt
cell
cell
coexpress
marker
net
result
cell
express
memori
phenotyp
marker
may
deriv
differ
sourc
rest
nonlymphopen
condit
bona
fide
memori
hp
cell
undergo
steadi
state
low
basal
level
divis
maintain
tcell
number
keep
cell
differ
specif
proport
frequenc
like
cell
similar
divis
rate
number
cell
remain
either
limit
protect
nich
lymphoid
organ
divis
give
rise
one
surviv
one
dead
daughter
question
resolv
steadi
state
lowlevel
prolifer
also
refer
homeostat
prolifer
driven
antigen
requir
mhccontain
environ
least
partial
depend
signal
steadyst
homeostasi
proport
bona
fide
memori
cell
rest
immunolog
environ
stabl
long
period
time
studi
mice
shown
tcell
memori
stabl
report
suggest
tcell
memori
gradual
wane
point
controversi
support
studi
time
debat
whether
antigen
need
preserv
tcell
memori
concept
refut
adopt
transfer
studi
show
memori
cell
could
maintain
environ
lack
express
mhc
antigen
experi
perform
fulli
differenti
memori
cell
evid
suggest
inadequ
prime
cell
may
lead
less
stabl
memori
cell
nevertheless
human
vvspecif
cell
found
sever
decad
immun
recent
quantit
longitudin
studi
shown
moder
declin
still
impress
tand
bcell
memori
vv
similar
period
suggest
appar
better
protect
memori
induc
attenu
rather
inactiv
viral
vaccin
unclear
whether
benefit
attenu
vaccin
gener
stronger
immun
respons
first
place
replic
antigen
gener
respons
bias
cell
persist
antigen
continu
stimul
respons
time
data
shown
heterolog
viral
infect
caus
substanti
reduct
memori
previous
encount
pathogen
natur
individu
constantli
challeng
infect
differ
pathogen
persist
antigen
may
counter
balanc
loss
memori
would
occur
infect
apoptosi
tcell
respons
tcell
number
regul
ratio
cell
divis
cell
death
usual
occur
apoptosi
import
distinguish
concept
cell
divis
cell
prolifer
latter
mean
increas
cell
number
divis
may
occur
without
increas
cell
number
case
steadyst
homeostasi
divid
cell
may
becom
sensit
variou
type
proapoptot
stimuli
divis
must
overcom
apoptosi
result
increas
number
dynam
cell
number
chang
lcmv
infect
mice
display
fig
initi
signific
loss
tcell
number
earli
stage
lcmv
mani
viral
infect
mice
human
expans
phase
virusspecif
cell
follow
divis
outpac
apoptosi
next
contract
silenc
phase
tcell
number
spleen
lymph
node
declin
apoptosi
migrat
peripher
tissu
paramet
respons
similar
mous
human
mani
viral
infect
mous
human
induc
substanti
loss
lymphocyt
leukocyt
number
earli
stage
infect
undoubtedli
may
mani
mechan
loss
cell
number
common
mediat
may
type
ifn
induc
high
level
earli
stage
infect
direct
respons
viral
replic
substanti
loss
tcell
number
first
five
day
lcmv
infect
parallel
level
type
ifn
product
occur
type
ifn
receptor
knockout
mice
block
antibodi
type
ifn
mimick
ifninduc
tlr
agonist
poli
c
cell
suffer
highest
level
apoptosi
hi
cell
cell
activ
caspas
express
phosphatidyl
serin
membran
interact
annexin
v
apoptot
loss
either
memori
lesser
extent
cell
occur
prior
cell
divis
shown
bromodeoxyuridin
uptak
studi
vivo
implant
csfelabel
cell
mice
look
loss
csfe
stain
indic
cell
divis
versu
apoptosi
earli
apoptosi
cell
inhibit
stimul
cell
ligand
inject
mice
enough
lcmv
epitop
gp
caus
activ
gp
specif
transgen
memori
cell
vivo
regard
upregul
inhibit
lcmvor
poli
c
induc
apoptosi
cell
find
interest
model
tcell
activ
indic
exposur
cell
ligand
especi
context
proper
costimul
caus
upregul
antiapoptot
factor
bclxl
protect
divid
cell
apoptosi
comput
model
howev
indic
without
apoptosi
memori
cell
earli
stage
infect
crossreact
cell
might
domin
respons
infect
select
reduc
frequenc
memori
cell
begin
immun
respons
may
highli
divers
tcell
respons
new
pathogen
high
divers
may
benefici
pathogen
control
type
ifn
appear
play
number
role
earli
stage
tcell
respons
major
effect
differenti
antigenpres
dendrit
cell
act
somewhat
surprisingli
signal
transduc
activ
transcript
depend
pathway
recent
work
growth
inhibitori
function
type
ifn
might
link
proapoptot
properti
implic
import
signal
pathway
interest
cell
downregul
activ
becom
resist
growth
inhibitori
effect
ifn
type
ifn
also
induc
divis
memori
cell
abil
induc
memori
cell
express
receptor
also
mediat
homeostat
divis
togeth
seem
type
ifn
first
caus
apoptosi
memori
cell
gener
lymphopen
state
stimul
divid
lymphopen
state
correct
overshoot
number
unless
antigen
drive
new
immun
respons
contract
silenc
phase
peak
tcell
respons
activ
cell
spleen
lymph
node
express
elev
level
fa
fa
ligand
fasl
becom
suscept
antigendriven
activationinduc
cell
death
aicd
express
preapoptot
phenotyp
indic
stain
annexin
v
maintain
function
cytotox
cytokin
product
controversi
concern
whether
stain
annexin
v
realli
mean
impend
apoptosi
whether
might
marker
tcell
activ
studi
show
fate
lcmvspecif
annexin
v
cell
introduc
cultur
vitro
fragment
dna
complet
apoptot
process
transfer
mice
vivo
annexin
v
cell
popul
gradual
decreas
number
fail
mediat
recal
respons
wherea
similarli
transfer
annexin
vcell
could
mediat
recal
respons
correl
made
cell
annexin
vand
express
receptor
express
cell
bear
high
concentr
antiapoptot
marker
precursor
fulli
function
memori
cell
thu
feel
annexin
v
inde
harbing
apoptosi
though
apoptosi
necessarili
happen
immedi
part
silenc
phase
associ
dissemin
cell
spleen
lymph
node
peripher
organ
commonli
state
activ
cell
die
apoptosi
number
base
examin
tcell
frequenc
lymphoid
tissu
one
studi
influenza
system
indic
much
smaller
reduct
cell
bodi
ad
featur
lcmvspecif
cell
peripheri
mean
lung
viscer
fat
periton
caviti
differ
apoptot
phenotyp
present
spleen
lymph
node
time
peripher
cell
react
less
annexin
v
express
stain
less
antibodi
fa
fasl
rel
resist
ligandtrigg
aicd
lcmv
system
part
resist
periton
cell
aicd
link
presenc
transform
growth
factorb
lung
influenzainfect
mice
resist
apoptosi
link
collagen
lung
signal
integrin
express
cell
signal
certain
integrin
adhes
molecul
long
known
render
cell
resist
apoptosi
chang
tissu
environ
cell
may
well
alter
apoptot
properti
signific
find
may
relat
fact
effector
memori
cell
may
linger
peripher
tissu
long
clearanc
viru
provid
potenti
fast
act
line
defens
pathogen
intrigu
aspect
apoptosi
cell
epitopespecif
prefer
regard
degre
apoptosi
easili
seen
lcmv
infect
mice
cell
specif
b
restrict
np
epitop
express
higher
annexin
v
reactiv
higher
fa
lower
higher
mitochondri
membran
potenti
cell
specif
b
restrict
gp
epitop
find
might
explain
fact
cell
specif
epitop
may
trigger
often
gp
epitop
lcmv
np
express
much
higher
level
gp
lcmv
infect
cell
howev
vv
recombin
express
np
versu
gprotein
similar
promot
stimul
cell
apoptot
properti
nevertheless
np
epitop
high
affin
binder
b
may
still
express
better
gp
intrigu
howev
differenti
apoptosi
np
gp
also
seen
secondari
immun
would
less
antigen
present
rest
immun
state
antigen
apoptot
level
lower
rest
immun
state
apoptot
differenti
versu
cell
remain
seem
apoptot
properti
epitopespecif
cell
intrins
properti
epitop
presum
learn
earli
phase
infect
imprint
perman
cell
one
might
expect
ratio
np
gp
specif
cell
chang
rest
memori
state
inde
moder
shift
gp
domin
time
within
otherwis
moder
stabl
memori
popul
caveat
subtl
shift
hierarchi
cell
differ
apoptot
properti
studi
infect
lcmv
pv
vv
mcmv
vsv
indic
tcell
memori
gener
quit
stabl
well
year
significantli
reduc
subsequ
infect
heterolog
virus
littl
inform
avail
concern
stabil
tcell
memori
human
studi
done
persist
viru
infect
hiv
ebv
cmv
hcv
repeatedli
encount
pathogen
like
influenza
viru
recent
studi
individu
immun
vv
small
pox
vaccin
indic
rel
stabl
memori
popul
sever
decad
though
memori
frequenc
declin
necessari
determin
whether
vvspecif
tcell
repertoir
remain
stabl
time
assess
stabl
memori
studi
mous
suggest
vv
may
highli
crossreact
virus
invit
possibl
vvspecif
cell
may
maintain
crossreact
fig
loss
preexist
memori
subsequ
infect
also
clarifi
human
infect
larger
immun
system
human
may
abl
accommod
larg
pool
new
memori
cell
without
exclud
other
somewhat
stabl
vvimmun
frequenc
assum
cell
maintain
crossreact
might
argu
loss
memori
major
issu
human
infect
howev
infect
drive
memori
loss
mice
major
system
infect
caus
substanti
lymphopenia
splenomegali
one
might
expect
substanti
memori
loss
occur
frequent
children
rather
adult
mani
diseas
natur
propos
two
model
explain
loss
preexist
memori
occur
consequ
heterolog
viral
infect
activ
attrit
model
wherebi
someth
directli
kill
memori
cell
passiv
attrit
model
newli
form
memori
cell
compet
previous
form
memori
cell
protect
nich
spleen
lymph
node
immun
respons
contract
although
mechan
might
influenc
surviv
memori
data
support
activ
model
occur
earli
cytokineinduc
lymphopenia
phase
infect
quantifi
preexist
antigenspecif
memori
cell
follow
frequenc
cours
infect
clear
number
go
earli
virusinduc
lymphopenia
recoveri
rather
modest
may
still
accommod
issu
compet
protect
nich
later
infect
rel
import
seem
less
activ
attrit
model
infect
virusinduc
lymphopenia
commonli
describ
event
occur
mani
human
infect
includ
influenza
west
nile
ebola
hiv
sever
acut
respiratori
syndrom
corona
even
human
lcmv
suspect
factor
drive
attrit
memori
human
littl
analysi
effect
human
virusinduc
lymphopenia
memori
antigen
though
known
patient
receiv
ifn
therapi
least
initi
loss
memori
phenotyp
cell
type
issu
examin
control
vaccin
studi
vaccin
may
drive
level
lymphopenia
necessari
caus
loss
memori
otherwis
vaccine
would
get
sick
issu
may
best
address
mani
volunt
get
bad
reaction
small
pox
vaccin
memori
cell
attrit
persist
infect
tcell
dynam
greatli
alter
persist
infect
induc
proapoptot
cytokin
also
drive
cell
apoptot
delet
aicd
function
exhaust
studi
shown
memori
cell
specif
heterolog
virus
greatli
delet
initi
infect
high
dose
lcmv
clone
caus
persist
infect
cell
rebound
frequenc
addit
csfelabel
memori
cell
transfer
mice
persist
infect
lcmv
clone
attempt
modest
level
homeostat
divis
rapidli
elimin
similar
mechan
occur
human
would
suggest
persist
infect
hiv
hcv
vigor
delet
memori
everyth
els
receiv
restimul
antigen
crossreact
antigen
persist
human
infect
could
residu
memori
cell
specif
nonpersist
antigen
crossreact
pathogen
drive
infect
failur
deplet
memori
cell
popul
recov
residu
popul
memori
cell
remain
earli
cytokineinduc
delet
infect
ineffect
restor
popul
frequenc
ineffect
two
reason
first
compet
antigenspecif
cell
respond
ongo
infect
antigendriven
prolifer
three
four
divis
per
day
occur
much
higher
rate
homeostat
divis
preexist
memori
cell
compet
second
factor
bona
fide
memori
cell
effect
homeostat
prolifer
first
place
even
absenc
infect
csfelabel
lcmvimmun
splenocyt
transfer
tcelldefici
mice
mice
render
lymphopen
irradi
poli
c
inocul
proport
lcmvspecif
cell
reconstitut
popul
cell
becam
comparison
start
frequenc
substanti
reduc
cell
prolifer
fill
lymphopen
environ
thu
memori
cell
compet
poorli
hp
cell
respond
selfantigen
microbi
flora
predict
condit
human
caus
lymphopenia
infect
irradi
immunosuppress
drug
treatment
induc
memori
cell
loss
need
test
human
well
mice
immun
system
evolv
multipl
divers
antigenspecif
memori
tcr
repertoir
accumul
lifetim
new
infect
memori
cell
must
compet
limit
space
competit
least
partial
accomplish
preferenti
loss
prior
memori
popul
activ
cytokinedepend
mechan
also
memori
cell
specif
previous
encount
pathogen
also
crossreact
newli
encount
pathogen
preferenti
maintain
expand
tcell
repertoir
specif
previou
pathogen
becom
perman
alter
fig
activ
crossreact
memori
cell
play
role
heterolog
immun
modul
tcell
immun
hierarchi
privat
specif
individu
antigenspecif
tcr
repertoir
lead
alter
balanc
protect
immun
immunopatholog
virusspecif
tcell
respons
crossreact
alloantigen
also
alter
memori
allospecif
tcell
pool
influenc
graft
reject
toler
induct
thu
get
wrong
infect
host
particular
mhc
wrong
time
sequenc
infect
might
signific
consequ
host
understand
fine
balanc
memori
cell
play
induct
protect
immun
versu
patholog
need
learn
consequ
heterolog
immun
crossreact
tcell
respons
